Complete Wegovy vs Mounjaro Dosing Comparison
Wegovy vs Mounjaro Dosage Chart: Understanding Prescription Weight Loss Options
When comparing the Wegovy vs Mounjaro dosage chart for prescription weight loss, the fundamental difference lies in their mechanisms and escalation schedules. Wegovy follows a 16-week dose escalation from 0.25mg to the maintenance dose of 2.4mg weekly, designed to minimise gastrointestinal side effects whilst building therapeutic efficacy. Mounjaro utilises a different 4-step approach, starting at 2.5mg and increasing every 4 weeks to a maximum of 15mg weekly. Both prescription-only medicines require clinical assessment and ongoing medical supervision throughout treatment.
The Wegovy vs Mounjaro dosage chart comparison reveals distinct approaches to GLP-1 pathway activation, with Wegovy targeting GLP-1 receptors exclusively whilst Mounjaro adds GIP receptor stimulation. This dual-pathway mechanism in Mounjaro may influence dosing intervals and therapeutic response patterns. Understanding these dosage differences helps patients and prescribers make informed decisions about which treatment schedule best suits individual tolerance levels and weight management objectives.
Wegovy vs Mounjaro Dosage Chart Pricing and Value Breakdown
Examining the Wegovy vs Mounjaro dosage chart reveals significant pricing considerations across treatment phases. Wegovy starter doses begin at £79.99 for the initial 0.25mg pen (weeks 1-4), progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the maintenance 2.4mg dose. Our Intro Trio bundle provides the first three escalation doses (0.25mg, 0.5mg, and 1mg) for £299.99, ensuring seamless progression through the critical initiation period. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive rates.
The structured Wegovy vs Mounjaro dosage chart approach means treatment costs vary depending on which escalation phase you're entering. Our Getting Started bundles address this by pairing consecutive doses - the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is £189.99. For patients requiring maintenance stability, our Ultimate Stability Trio provides three months of 2.4mg supply for £649.99. This comprehensive pricing structure across the Wegovy vs Mounjaro dosage chart comparison ensures transparent cost planning throughout your weight management journey.
Clinical Evidence Behind Wegovy vs Mounjaro Dosage Chart Protocols
The Wegovy vs Mounjaro dosage chart protocols emerged from extensive clinical trial programmes demonstrating different efficacy patterns. In the STEP trials, Wegovy's gradual escalation to 2.4mg resulted in approximately 15% average weight loss at 68 weeks when combined with lifestyle interventions (Wilding et al., NEJM, 2021). The dose escalation schedule was specifically designed to optimise tolerability whilst achieving therapeutic semaglutide concentrations.
When comparing the Wegovy vs Mounjaro dosage chart evidence base, both medications demonstrated substantial weight loss in their respective clinical programmes, though direct head-to-head comparisons weren't conducted. The structured dose escalation in both treatments helps patients adapt to GLP-1 pathway effects whilst building therapeutic response. Both medications are MHRA-licensed for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, supporting their inclusion in comprehensive weight management programmes.
How Wegovy Works Within the Dosage Chart Framework
Understanding how Wegovy functions within its dosage chart helps explain the structured escalation protocol from 0.25mg to 2.4mg weekly injections. As a GLP-1 receptor agonist, Wegovy mimics the natural incretin hormone that regulates blood glucose and gastric emptying, whilst directly influencing appetite centres in the brain. The gradual dose increases allow patients to adapt to enhanced satiety signals and reduced food cravings without overwhelming gastrointestinal adjustment. Each dose level in the Wegovy vs Mounjaro dosage chart builds therapeutic semaglutide exposure whilst monitoring individual tolerance and response. The 16-week escalation period ensures optimal therapeutic benefit whilst minimising discontinuation due to side effects. This patient-centred approach to the Wegovy dosage chart maximises long-term treatment adherence and sustainable weight management outcomes.
Wegovy vs Mounjaro Dosage Chart: Ordering Process
Accessing either medication through our Wegovy vs Mounjaro dosage chart requires completion of our 3-minute online clinical assessment, covering medical history, current medications, and weight management goals. Our GPhC-registered prescribers (#9012878) review each application within 3 working days, with 24-hour express review available for urgent requirements. Once approved, your chosen treatment ships via next-day cold-chain delivery, maintaining the 2-8°C storage requirements critical for both medications. Our clinical team provides ongoing support throughout your dose escalation journey, whether following Wegovy's 5-step protocol or Mounjaro's alternative schedule. This streamlined process ensures you receive expert medical oversight whilst accessing competitive pricing across the complete Wegovy vs Mounjaro dosage chart spectrum.
Storage and Practical Considerations in Wegovy vs Mounjaro Dosage Chart
Practical storage requirements differ significantly in the Wegovy vs Mounjaro dosage chart comparison, particularly for patients who travel frequently or have variable schedules. Wegovy pens maintain stability for up to 6 weeks at room temperature (below 30°C) once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications arrive in temperature-controlled packaging and should be stored at 2-8°C before first use, with the FlexTouch pen design ensuring accurate dosing throughout the escalation schedule. The weekly injection schedule for both treatments allows flexible timing, though consistency helps maintain steady therapeutic levels. Each dose escalation in the Wegovy vs Mounjaro dosage chart requires a new pen strength, making our bundle options particularly valuable for ensuring treatment continuity. Proper storage and handling throughout the dosage progression maintains medication efficacy and supports optimal therapeutic outcomes.
Wegovy vs Mounjaro Dosage Chart: Personalised Treatment Selection
Choosing between treatment options requires understanding how individual factors influence dosage chart selection and therapeutic response patterns. The Wegovy vs Mounjaro dosage chart comparison reveals different approaches to appetite regulation and metabolic enhancement, with some patients responding preferentially to single-pathway GLP-1 stimulation versus dual-receptor activation. Our prescribers evaluate medical history, concurrent medications, and previous weight management experiences when recommending which dosage protocol best suits individual circumstances.
The structured nature of both dosage charts allows for personalised titration based on tolerance and efficacy markers throughout treatment. Some patients may benefit from extended time at lower Wegovy doses before progression, whilst others tolerate rapid escalation to maintenance levels. Both treatments in our Wegovy vs Mounjaro dosage chart require commitment to reduced-calorie diet and increased physical activity for optimal results. Our clinical team provides ongoing support to ensure your chosen dosage protocol delivers sustainable weight management outcomes aligned with your health objectives.
Starting Your Wegovy vs Mounjaro Dosage Chart Journey
Beginning treatment through our comprehensive Wegovy vs Mounjaro dosage chart service starts with understanding which medication aligns with your clinical profile and lifestyle requirements. New customers can access our complete range from £79.99 using code FIRST40 at checkout, whilst returning patients apply DOSE25 for continued savings across all dosage levels. Our bundle options support seamless progression through escalation phases, whether following Wegovy's 16-week protocol or Mounjaro's alternative schedule. Both treatments require prescription-only medicine oversight and ongoing clinical monitoring throughout the dosage progression. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and discover which treatment option best supports your weight management goals. Both Wegovy and Mounjaro are available from EverydayMeds - your prescriber can help determine which dosage chart approach is right for your individual circumstances.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
